Elanco Animal Health (ELAN) Stock Insights
ELAN$23.09+0.43 +1.92%
$11.53B
Market Cap
-55.24
P/E
20.39
Forward P/E
46
Score
Elanco Animal Health (ELAN) Stock Insights
ELAN price $23.09 +0.43 +1.92%
- Ticker
- ELAN
- Price
- $23.09
- Change
- +0.43 +1.92%
- Market cap ?
- $11.53B
- P/E ?
- -55.24
- Forward P/E ?
- 20.39
- Dividend yield ?
- 0.00%
- Beta ?
- 1.71
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stocklytics score
- 46
- Value
- 44
- Quality
- 42
- Growth
- 52
Stocklytics score rationale: value 44, quality 42, growth 52.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 2913500000 | 2889000000 | 3066800000 | 3071000000 | 3273300000 | 4764000000 | 4411000000 | 4417000000 | 4439000000 | 4715000000 |
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and…
Fair value
ELAN fair value $25.68. Price $23.09. Price is 10% below fair value.
Above fair value, but less expensive than usual. A smaller premium than on 80% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 379.00M. Growth 13.86%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.7). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 499.45M. Net debt 3.47B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-06 | — | 0.20 | — | 1.21B |
| 2026-08-05 | 0.34 | 0.27 | 1.37B | 1.31B |
| 2026-05-06 | 0.40 | 0.35 | 1.37B | 1.28B |
| 2026-02-24 | 0.13 | 0.11 | 1.14B | 1.09B |
| 2025-11-05 | 0.19 | 0.13 | 1.14B | 1.09B |
| 2025-08-07 | 0.26 | 0.20 | 1.24B | 1.09B |
| 2025-05-07 | 0.37 | 0.31 | 1.19B | 1.18B |
| 2025-02-25 | 0.14 | 0.16 | 1.02B | 1.21B |
| 2024-11-07 | 0.13 | 0.12 | 1.03B | 1.01B |
| 2024-08-08 | 0.30 | 0.24 | 1.18B | 1.15B |
| 2024-05-08 | 0.34 | 0.27 | 1.21B | 1.19B |
| 2024-02-26 | 0.08 | 0.10 | 1.03B | 1.00B |
| 2023-11-07 | 0.18 | 0.12 | 1.07B | 1.04B |
| 2023-08-07 | 0.18 | 0.05 | 1.06B | 1.04B |
| 2023-05-09 | 0.45 | 0.29 | 1.26B | 1.18B |
| 2023-02-21 | 0.19 | 0.13 | 988.00M | 980.94M |
| 2022-11-08 | 0.20 | 0.16 | 1.03B | 1.03B |
| 2022-08-08 | 0.36 | 0.26 | 1.18B | 1.18B |
| 2022-05-09 | 0.36 | 0.35 | 1.23B | 1.22B |
| 2022-02-24 | 0.21 | 0.17 | 1.11B | 1.10B |
| 2021-11-05 | 0.19 | 0.17 | 1.13B | 1.11B |
| 2021-08-09 | 0.28 | 0.26 | 1.28B | 1.28B |
| 2021-05-07 | 0.37 | 0.23 | 1.24B | 1.16B |
| 2021-02-24 | 0.12 | 0.09 | 1.14B | 759.80M |
| 2020-11-06 | 0.13 | 0.12 | 889.60M | 815.47M |
| 2020-07-30 | 0.09 | 0.02 | 586.30M | 390.87M |
| 2020-05-07 | 0.13 | 0.24 | 657.70M | 1.21B |
| 2020-02-19 | 0.23 | 0.23 | 787.00M | 787.00M |
| 2019-11-06 | 0.30 | 0.26 | 771.30M | 668.46M |
| 2019-08-13 | 0.28 | 0.26 | 781.60M | 725.77M |
| 2019-05-09 | 0.25 | 0.22 | 731.10M | 672.61M |
| 2019-02-06 | 0.29 | 0.26 | 799.30M | 771.74M |
| 2018-11-06 | 0.29 | 0.24 | 761.10M | 639.32M |
| 2018-09-21 | -0.18 | — | 770.20M | — |
| 2018-03-31 | 0.20 | — | 736.20M | — |
| 2017-12-31 | -0.44 | — | 754.30M | — |
| 2017-09-30 | -0.06 | — | 697.10M | — |
| 2017-06-30 | -0.18 | — | 718.80M | — |
| 2017-03-31 | -0.18 | — | 718.80M | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-16 | Modi Rajeev A. | Buy | 63 | $23.55 | 1.48K |
| 2026-10-16 | Simmons Jeffrey N | Buy | 120 | $23.55 | 2.83K |
| 2026-10-16 | VanHimbergen Robert M | Buy | 8 | $23.55 | 197 |
| 2026-10-15 | Bettington Timothy J | Sell | 4.35K | $23.00 | 100.05K |
| 2026-10-02 | Modi Rajeev A. | Buy | 67 | $22.14 | 1.48K |
| 2026-10-02 | Simmons Jeffrey N | Buy | 128 | $22.14 | 2.83K |
| 2026-10-02 | VanHimbergen Robert M | Buy | 9 | $22.14 | 197 |
| 2026-09-30 | Anand Kapila K | Buy | 642 | $22.39 | 14.38K |
| 2026-09-18 | Simmons Jeffrey N | Buy | 126 | $22.42 | 2.83K |
| 2026-09-18 | Modi Rajeev A. | Buy | 66 | — | — |
| 2026-09-18 | VanHimbergen Robert M | Buy | 9 | — | — |
| 2026-09-04 | VanHimbergen Robert M | Buy | 8 | — | — |
| 2026-09-04 | Modi Rajeev A. | Buy | 60 | — | — |
| 2026-09-04 | Simmons Jeffrey N | Buy | 115 | — | — |
| 2026-08-21 | Modi Rajeev A. | Buy | 62 | — | — |
| 2026-08-21 | VanHimbergen Robert M | Buy | 8 | — | — |
| 2026-08-21 | Simmons Jeffrey N | Buy | 118 | — | — |
| 2026-08-20 | Kurzius Lawrence Erik | Buy | 40.00K | $23.40 | 935.92K |
| 2026-08-18 | O'Neill Shiv | Buy | 4.00K | $23.58 | 94.27K |
| 2026-08-12 | Harrington Michael J | Buy | 5.00K | $21.82 | 109.10K |
| 2026-08-07 | Simmons Jeffrey N | Buy | 128 | — | — |
| 2026-08-07 | VanHimbergen Robert M | Buy | 4.20K | $23.08 | 96.93K |
| 2026-08-07 | VanHimbergen Robert M | Buy | 9 | — | — |
| 2026-08-07 | Modi Rajeev A. | Buy | 67 | — | — |
| 2026-08-07 | Herendeen Paul | Buy | 10.00K | $23.68 | 236.85K |
| 2026-07-24 | Simmons Jeffrey N | Buy | 113 | — | — |
| 2026-07-24 | Modi Rajeev A. | Buy | 59 | — | — |
| 2026-07-24 | VanHimbergen Robert M | Buy | 8 | — | — |
| 2026-07-10 | Simmons Jeffrey N | Buy | 114 | — | — |
| 2026-07-10 | VanHimbergen Robert M | Buy | 8 | — | — |
| 2026-07-10 | Modi Rajeev A. | Buy | 60 | — | — |
| 2026-07-07 | VanHimbergen Robert M | Sell | 15.34K | $24.64 | 377.88K |
| 2026-07-01 | Kinard David S | Buy | 25.62K | $24.09 | 617.19K |
| 2026-06-30 | Anand Kapila K | Buy | 584 | — | — |
| 2026-06-26 | Modi Rajeev A. | Buy | 60 | — | — |
| 2026-06-26 | Simmons Jeffrey N | Buy | 115 | — | — |
| 2026-06-26 | VanHimbergen Robert M | Buy | 8 | — | — |
| 2026-06-12 | VanHimbergen Robert M | Buy | 8 | — | — |
| 2026-06-12 | Simmons Jeffrey N | Buy | 117 | — | — |
| 2026-06-12 | Modi Rajeev A. | Buy | 61 | — | — |
| 2026-05-29 | VanHimbergen Robert M | Buy | 8 | — | — |
| 2026-05-29 | Modi Rajeev A. | Buy | 62 | — | — |
| 2026-05-29 | Simmons Jeffrey N | Buy | 119 | — | — |
| 2026-05-21 | Scots-Knight Denise | Buy | 12.20K | — | — |
| 2026-05-21 | Scots-Knight Denise | Buy | 4.68K | — | — |
| 2026-05-21 | Kurzius Lawrence Erik | Buy | 12.20K | — | — |
| 2026-05-21 | Kurzius Lawrence Erik | Buy | 4.68K | — | — |
| 2026-05-21 | McDonald Kirk P | Buy | 12.20K | — | — |
| 2026-05-21 | McDonald Kirk P | Buy | 4.68K | — | — |
| 2026-05-21 | Herendeen Paul | Buy | 12.20K | — | — |
| 2026-05-21 | Herendeen Paul | Buy | 4.68K | — | — |
| 2026-05-21 | Kochevar Deborah Turner | Buy | 4.68K | — | — |
| 2026-05-21 | HOOVER R DAVID | Buy | 4.68K | — | — |
| 2026-05-21 | Harrington Michael J | Buy | 12.20K | — | — |
| 2026-05-21 | Harrington Michael J | Buy | 4.68K | — | — |
| 2026-05-21 | Anand Kapila K | Buy | 12.20K | — | — |
| 2026-05-21 | Anand Kapila K | Buy | 4.68K | — | — |
| 2026-05-21 | Ma Stacey | Buy | 12.20K | — | — |
| 2026-05-21 | Ma Stacey | Buy | 4.68K | — | — |
| 2026-05-21 | GARCIA ART A | Buy | 12.20K | — | — |
| 2026-05-21 | GARCIA ART A | Buy | 4.68K | — | — |
| 2026-05-15 | Modi Rajeev A. | Buy | 4.91K | $20.35 | 99.94K |
| 2026-05-15 | Modi Rajeev A. | Buy | 74 | — | — |
| 2026-05-15 | Simmons Jeffrey N | Buy | 4.97K | $20.09 | 99.84K |
| 2026-05-15 | Simmons Jeffrey N | Buy | 142 | — | — |
| 2026-05-15 | VanHimbergen Robert M | Buy | 10 | — | — |
| 2026-05-01 | Modi Rajeev A. | Buy | 66 | — | — |
| 2026-05-01 | Simmons Jeffrey N | Buy | 126 | — | — |
| 2026-05-01 | VanHimbergen Robert M | Buy | 9 | — | — |
| 2026-04-17 | Simmons Jeffrey N | Buy | 119 | — | — |
| 2026-04-17 | VanHimbergen Robert M | Buy | 8 | — | — |
| 2026-04-17 | Modi Rajeev A. | Buy | 62 | — | — |
| 2026-04-03 | Modi Rajeev A. | Buy | 65 | — | — |
| 2026-04-03 | Simmons Jeffrey N | Buy | 124 | — | — |
| 2026-04-03 | VanHimbergen Robert M | Buy | 9 | — | — |
| 2026-04-01 | de Brabander Ellen | Buy | 40.98K | — | — |
| 2026-04-01 | de Brabander Ellen | Sell | 20.29K | $23.12 | 469.06K |
| 2026-03-31 | Anand Kapila K | Buy | 601 | — | — |
| 2026-03-20 | Simmons Jeffrey N | Buy | 118 | — | — |
| 2026-03-20 | Modi Rajeev A. | Buy | 62 | — | — |
| 2026-03-20 | VanHimbergen Robert M | Buy | 8 | — | — |
| 2026-03-06 | Modi Rajeev A. | Buy | 1.36K | — | — |
| 2026-03-06 | Simmons Jeffrey N | Buy | 4.50K | — | — |
| 2026-03-06 | VanHimbergen Robert M | Buy | 9 | — | — |
| 2026-03-06 | Correia de Simas Jose Manuel | Buy | 17.64K | — | — |
| 2026-03-03 | Modi Rajeev A. | Sell | 4.39K | $24.88 | 109.27K |
| 2026-03-03 | O'Neill Shiv | Sell | 4.74K | $24.88 | 117.88K |
| 2026-03-03 | Simmons Jeffrey N | Sell | 37.90K | $24.88 | 942.90K |
| 2026-03-03 | Bettington Timothy J | Sell | 4.70K | $24.88 | 116.81K |
| 2026-03-03 | Cabral Ramiro Martin | Sell | 6.49K | $24.88 | 161.52K |
| 2026-03-03 | Correia de Simas Jose Manuel | Sell | 3.37K | $24.88 | 83.87K |
| 2026-03-03 | de Brabander Ellen | Sell | 8.26K | $24.88 | 205.56K |
| 2026-03-03 | Kinard David S | Sell | 3.43K | $24.88 | 85.41K |
| 2026-03-03 | McArdle Grace | Sell | 4.32K | $24.88 | 107.53K |
| 2026-03-03 | Meer James M | Sell | 1.39K | $24.88 | 34.56K |
| 2026-03-01 | Meer James M | Buy | 5.21K | — | — |
| 2026-03-01 | Meer James M | Buy | 9.60K | — | — |
| 2026-03-01 | Meer James M | Sell | 4.79K | $26.40 | 126.38K |
| 2026-03-01 | Modi Rajeev A. | Buy | 41.69K | — | — |
| 2026-03-01 | Modi Rajeev A. | Buy | 14.21K | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 535, holders +2 vs prior quarter. Ownership 114.22%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| DODGE & COX | 67.40M | -1.55M | -2.24% | 1.66B |
| FMR LLC | 56.95M | 6.02M | +11.83% | 1.40B |
| BLACKROCK, INC. | 48.85M | 1.23M | +2.58% | 1.20B |
| PRIMECAP MANAGEMENT CO/CA/ | 45.45M | -395.94K | -0.86% | 1.12B |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 28.75M | -5.88M | -16.99% | 707.56M |
| DIMENSIONAL FUND ADVISORS LP | 25.42M | 890.14K | +3.63% | 625.53M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 22.67M | 34.95K | +0.15% | 557.97M |
| VANGUARD CAPITAL MANAGEMENT LLC | 22.61M | 271.41K | +1.22% | 556.37M |
| STATE STREET CORP | 16.06M | 726.57K | +4.74% | 395.31M |
| WINSLOW CAPITAL MANAGEMENT, LLC | 13.51M | -103.23K | -0.76% | 332.51M |
| BLACK CREEK INVESTMENT MANAGEMENT INC. | 13.05M | 2.55M | +24.32% | 321.07M |
| GEODE CAPITAL MANAGEMENT, LLC | 11.30M | 109.65K | +0.98% | 278.20M |
| UBS GROUP AG | 9.91M | 1.34M | +15.62% | 243.91M |
| CITADEL ADVISORS LLC | 9.67M | 5.28M | +120.39% | 237.94M |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 8.36M | 2.13M | +34.14% | 205.64M |
| MORGAN STANLEY | 7.85M | 1.44M | +22.39% | 193.30M |
| FULLER & THALER ASSET MANAGEMENT, INC. | 6.24M | 225.18K | +3.74% | 153.57M |
| INVESCO LTD. | 5.31M | -2.83M | -34.82% | 130.59M |
| SEI INVESTMENTS CO | 5.28M | -365.62K | -6.47% | 130.06M |
| JENNISON ASSOCIATES LLC | 4.51M | 1.39M | +44.47% | 110.95M |
| MARSHALL WACE, LLP | 4.43M | 3.05M | +220.62% | 109.08M |
| NORTHERN TRUST CORP | 4.26M | 66.87K | +1.60% | 104.74M |
| JUPITER ASSET MANAGEMENT LTD | 4.22M | 1.11M | +35.67% | 103.84M |
| BANK OF AMERICA CORP /DE/ | 3.91M | 551.66K | +16.43% | 96.22M |
| CLEARBRIDGE INVESTMENTS, LLC | 3.72M | -864.84K | -18.88% | 91.46M |
Insights
- Revenue by product
- Revenue by region
| Period | Value |
|---|---|
| FY2018 | Companion Animal Disease Prevention: 804600000.0, Companion Animal Other: 93900000.0, Companion Animal Therapeutics: 283100000.0, Food Animal Future Protein And Health: 711200000.0, Food Animal Ruminants And Swine: 1174000000.0 |
| FY2019 | Companion Animal Disease Prevention: 787900000.0, Companion Animal Therapeutics: 348000000.0, Food Animal Future Protein And Health: 745100000.0, Food Animal Ruminants And Swine: 1110300000.0, Product Category Strategic Exits: 79700000.0 |
| FY2020 | Contract Manufacturing: 80200000.0, Farm Animal Future Protein And Health: 734100000.0, Farm Animal Ruminants And Swine: 1100500000.0, Pet Health Disease Prevention: 992700000.0, Pet Health Therapeutics: 365800000.0 |
| FY2021 | Contract Manufacturing: 82000000.0, Farm Animal: 2332000000.0, Pet Health: 2351000000.0 |
| FY2022 | Cattle: 944000000.0, Contract Manufacturing: 54000000.0, Farm Animal: 2219000000.0, Pet Health: 2138000000.0, Poultry: 716000000.0, Swine: 384000000.0 |
| FY2023 | Cattle: 949000000.0, Contract Manufacturing: 42000000.0, Farm Animal: 2271000000.0, Pet Health: 2104000000.0, Poultry: 765000000.0, Swine: 382000000.0 |
| FY2024 | Cattle: 1007000000.0, Contract Manufacturing: 46000000.0, Farm Animal: 2250000000.0, Pet Health: 2143000000.0, Poultry: 796000000.0, Swine: 366000000.0 |
| FY2025 | Cattle: 1125000000.0, Contract Manufacturing: 53000000.0, Farm Animal: 2362000000.0, Pet Health: 2300000000.0, Poultry: 858000000.0, Swine: 379000000.0 |
| Period | Value |
|---|---|
| FY2018 | Non-US: 1583600000.0, UNITED STATES: 1483200000.0 |
| FY2019 | Non-US: 1546300000.0, UNITED STATES: 1524700000.0 |
| FY2020 | Non-US: 1797700000.0, UNITED STATES: 1475600000.0 |
| FY2021 | Non-US: 2641000000.0, UNITED STATES: 2124000000.0 |
| FY2022 | Non-US: 2446000000.0, UNITED STATES: 1965000000.0 |
| FY2023 | Non-US: 2434000000.0, UNITED STATES: 1983000000.0 |
| FY2024 | Non-US: 2403000000.0, UNITED STATES: 2036000000.0 |
| FY2025 | Non-US: 2481000000.0, UNITED STATES: 2234000000.0 |
Insights · Dividends · Forecast · Financials · Learn